vs
Side-by-side financial comparison of Lucid Diagnostics Inc. (LUCD) and XMax Inc. (XWIN). Click either name above to swap in a different company.
XMax Inc. is the larger business by last-quarter revenue ($1.8M vs $1.2M, roughly 1.5× Lucid Diagnostics Inc.). On growth, Lucid Diagnostics Inc. posted the faster year-over-year revenue change (3.3% vs -11.8%). Over the past eight quarters, Lucid Diagnostics Inc.'s revenue compounded faster (7.9% CAGR vs -13.7%).
Lucid Diagnostics Inc. is a commercial-stage medical diagnostics firm focused on non-invasive screening tests for upper gastrointestinal diseases, including early detection of esophageal cancer and pre-cancerous lesions. It mainly serves healthcare providers and clinical partners across the United States, targeting at-risk patient populations.
XMax Inc. is a global tech firm focused on Web3 gaming infrastructure and interactive entertainment solutions. It builds custom game development toolkits, decentralized asset systems and cross-platform gaming products for developers and consumers in North America, APAC and Europe.
LUCD vs XWIN — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2M | $1.8M |
| Net Profit | $-10.4M | — |
| Gross Margin | — | 40.3% |
| Operating Margin | -971.0% | -59.3% |
| Net Margin | -858.5% | — |
| Revenue YoY | 3.3% | -11.8% |
| Net Profit YoY | 16.0% | — |
| EPS (diluted) | $-0.10 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $1.8M | ||
| Q3 25 | $1.2M | $9.8M | ||
| Q2 25 | $1.2M | $2.6M | ||
| Q1 25 | $828.0K | $2.6M | ||
| Q4 24 | $1.2M | $2.0M | ||
| Q3 24 | $1.2M | $2.6M | ||
| Q2 24 | $976.0K | $2.7M | ||
| Q1 24 | $1.0M | $2.4M |
| Q4 25 | — | — | ||
| Q3 25 | $-10.4M | $-1.1M | ||
| Q2 25 | $-4.4M | $-289.9K | ||
| Q1 25 | $-26.9M | $-338.9K | ||
| Q4 24 | $-11.5M | — | ||
| Q3 24 | $-12.4M | $-2.5M | ||
| Q2 24 | $-11.0M | $-563.5K | ||
| Q1 24 | $-10.6M | $-1.5M |
| Q4 25 | — | 40.3% | ||
| Q3 25 | — | 10.1% | ||
| Q2 25 | — | 50.2% | ||
| Q1 25 | — | 45.7% | ||
| Q4 24 | — | 42.8% | ||
| Q3 24 | — | 45.1% | ||
| Q2 24 | — | 44.4% | ||
| Q1 24 | — | 42.8% |
| Q4 25 | — | -59.3% | ||
| Q3 25 | -971.0% | -5.0% | ||
| Q2 25 | -978.8% | -7.7% | ||
| Q1 25 | -1508.1% | -7.3% | ||
| Q4 24 | -1033.8% | -48.4% | ||
| Q3 24 | -997.8% | -92.0% | ||
| Q2 24 | -1146.7% | -18.5% | ||
| Q1 24 | -1078.1% | -62.6% |
| Q4 25 | — | — | ||
| Q3 25 | -858.5% | -11.5% | ||
| Q2 25 | -381.7% | -11.3% | ||
| Q1 25 | -3249.8% | -12.9% | ||
| Q4 24 | -964.2% | — | ||
| Q3 24 | -1055.5% | -94.3% | ||
| Q2 24 | -1127.6% | -21.0% | ||
| Q1 24 | -1060.1% | -61.6% |
| Q4 25 | — | $-0.06 | ||
| Q3 25 | $-0.10 | $-0.06 | ||
| Q2 25 | $-0.08 | $-0.02 | ||
| Q1 25 | $-0.52 | $-0.03 | ||
| Q4 24 | $-0.17 | $0.11 | ||
| Q3 24 | $-0.25 | $-0.72 | ||
| Q2 24 | $-0.23 | $-0.22 | ||
| Q1 24 | $-0.40 | $-0.65 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $47.3M | $6.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $25.8M | $28.0M |
| Total Assets | $53.2M | $35.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $6.7M | ||
| Q3 25 | $47.3M | $1.7M | ||
| Q2 25 | $31.1M | $468.8K | ||
| Q1 25 | $25.2M | $147.3K | ||
| Q4 24 | $22.4M | $161.9K | ||
| Q3 24 | $14.5M | $162.3K | ||
| Q2 24 | $24.9M | $363.4K | ||
| Q1 24 | $24.8M | $273.1K |
| Q4 25 | — | $28.0M | ||
| Q3 25 | $25.8M | $13.6M | ||
| Q2 25 | $7.9M | $6.5M | ||
| Q1 25 | $-5.4M | $6.8M | ||
| Q4 24 | $5.4M | $3.1M | ||
| Q3 24 | $6.3M | $-895.9K | ||
| Q2 24 | $16.0M | $48.2K | ||
| Q1 24 | $11.9M | $-42.7K |
| Q4 25 | — | $35.5M | ||
| Q3 25 | $53.2M | $18.3M | ||
| Q2 25 | $38.7M | $11.6M | ||
| Q1 25 | $32.8M | $11.9M | ||
| Q4 24 | $30.7M | $9.9M | ||
| Q3 24 | $22.6M | $5.1M | ||
| Q2 24 | $34.1M | $5.8M | ||
| Q1 24 | $32.0M | $6.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.9M | $1.7M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.7M | ||
| Q3 25 | $-10.9M | $-1.9M | ||
| Q2 25 | $-10.5M | $92.5K | ||
| Q1 25 | $-12.5M | $-322.6K | ||
| Q4 24 | $-9.9M | $-263.4K | ||
| Q3 24 | $-10.2M | $-437.9K | ||
| Q2 24 | $-11.5M | $-468.7K | ||
| Q1 24 | $-12.6M | $-221.7K |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LUCD
Segment breakdown not available.
XWIN
| North America | $1.7M | 97% |
| Other | $50.4K | 3% |
